RecruitingPhase 3NCT07691970
Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment
Sponsor: AstraZeneca
Portland, OR · +14 more sites
3 recruiting lupus studies with a site in Portland, OR.
Sponsor: AstraZeneca
Portland, OR · +14 more sites
Sponsor: AstraZeneca
Portland, OR · +21 more sites
Sponsor: CRISPR Therapeutics
Portland, OR · +8 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.